Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 6, 2017

Primary Completion Date

March 7, 2017

Study Completion Date

March 7, 2017

Conditions

Healthy

Interventions

DRUG

Omiganan

Omignan 1%, 2.5%

DRUG

Imiquimod

Imiquimod 15mg

DRUG

Omiganan 1% and Imiquimod

DRUG

Omiganan 2.5% and Imiquimod

DRUG

Placebo

Vehicle

Trial Locations (1)

LUMC/Centre for Human Drug Research, Leiden

All Listed Sponsors

lead

Maruho Co., Ltd.

INDUSTRY

NCT03071679 - Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers | Biotech Hunter | Biotech Hunter